Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2545 to 2548 of 2548 entries
Sorted by: Best Match Show Resources per page
Towards a European strategy to address the COVID-19 pandemic.

Lancet (London, England)

Priesemann V, Balling R, Bauer S, Beutels P, Valdez AC, Cuschieri S, Czypionka T, Dumpis U, Glaab E, Grill E, Hotulainen P, Iftekhar EN, Krutzinna J, Lionis C, Machado H, Martins C, McKee M, Pavlakis GN, Perc M, Petelos E, Pickersgill M, Prainsack B, Rocklöv J, Schernhammer E, Szczurek E, Tsiodras S, Van Gucht S, Willeit P.
PMID: 34384539
Lancet. 2021 Sep 04;398(10303):838-839. doi: 10.1016/S0140-6736(21)01808-0. Epub 2021 Aug 09.

No abstract available.

Cite
Priesemann V, Balling R, Bauer S, et al. Towards a European strategy to address the COVID-19 pandemic. Lancet. 2021;398(10303):838-839doi: 10.1016/S0140-6736(21)01808-0.
Priesemann, V., Balling, R., Bauer, S., Beutels, P., Valdez, A. C., Cuschieri, S., Czypionka, T., Dumpis, U., Glaab, E., Grill, E., Hotulainen, P., Iftekhar, E. N., Krutzinna, J., Lionis, C., Machado, H., Martins, C., McKee, M., Pavlakis, G. N., Perc, M., Petelos, E., Pickersgill, M., Prainsack, B., Rocklöv, J., Schernhammer, E., Szczurek, E., Tsiodras, S., Van Gucht, S., & Willeit, P. (2021). Towards a European strategy to address the COVID-19 pandemic. Lancet (London, England), 398(10303), 838-839. https://doi.org/10.1016/S0140-6736(21)01808-0
Priesemann, Viola, et al. "Towards a European strategy to address the COVID-19 pandemic." Lancet (London, England) vol. 398,10303 (2021): 838-839. doi: https://doi.org/10.1016/S0140-6736(21)01808-0
Priesemann V, Balling R, Bauer S, Beutels P, Valdez AC, Cuschieri S, Czypionka T, Dumpis U, Glaab E, Grill E, Hotulainen P, Iftekhar EN, Krutzinna J, Lionis C, Machado H, Martins C, McKee M, Pavlakis GN, Perc M, Petelos E, Pickersgill M, Prainsack B, Rocklöv J, Schernhammer E, Szczurek E, Tsiodras S, Van Gucht S, Willeit P. Towards a European strategy to address the COVID-19 pandemic. Lancet. 2021 Sep 04;398(10303):838-839. doi: 10.1016/S0140-6736(21)01808-0. Epub 2021 Aug 09. PMID: 34384539; PMCID: PMC8352491.
Copy Download .nbib Format: NLM
How resilient is health financing policy in Europe to economic shocks? Evidence from the first year of the COVID-19 pandemic and the 2008 global financial crisis.

Health policy (Amsterdam, Netherlands)

Thomson S, García-Ramírez JA, Akkazieva B, Habicht T, Cylus J, Evetovits T.
PMID: 34857406
Health Policy. 2022 Jan;126(1):7-15. doi: 10.1016/j.healthpol.2021.11.002. Epub 2021 Nov 15.

The COVID-19 pandemic triggered an economic shock just ten years after the shock of the 2008 global financial crisis. Economic shocks are a challenge for health systems because they reduce government revenue at the same time as they increase...

Cite
Thomson S, García-Ramírez JA, Akkazieva B, et al. How resilient is health financing policy in Europe to economic shocks? Evidence from the first year of the COVID-19 pandemic and the 2008 global financial crisis. Health Policy. 2021;126(1):7-15doi: 10.1016/j.healthpol.2021.11.002.
Thomson, S., García-Ramírez, J. A., Akkazieva, B., Habicht, T., Cylus, J., & Evetovits, T. (2022). How resilient is health financing policy in Europe to economic shocks? Evidence from the first year of the COVID-19 pandemic and the 2008 global financial crisis. Health policy (Amsterdam, Netherlands), 126(1), 7-15. https://doi.org/10.1016/j.healthpol.2021.11.002
Thomson, Sarah, et al. "How resilient is health financing policy in Europe to economic shocks? Evidence from the first year of the COVID-19 pandemic and the 2008 global financial crisis." Health policy (Amsterdam, Netherlands) vol. 126,1 (2022): 7-15. doi: https://doi.org/10.1016/j.healthpol.2021.11.002
Thomson S, García-Ramírez JA, Akkazieva B, Habicht T, Cylus J, Evetovits T. How resilient is health financing policy in Europe to economic shocks? Evidence from the first year of the COVID-19 pandemic and the 2008 global financial crisis. Health Policy. 2022 Jan;126(1):7-15. doi: 10.1016/j.healthpol.2021.11.002. Epub 2021 Nov 15. PMID: 34857406; PMCID: PMC8591973.
Copy Download .nbib Format: NLM
hGLUTEN Tool: Measuring Its Social Impact Indicators.

International journal of environmental research and public health

Moreno A, Sanz G, Garcia-Zapirain B.
PMID: 34886446
Int J Environ Res Public Health. 2021 Dec 02;18(23). doi: 10.3390/ijerph182312722.

hGLUTEN is a technological solution capable of detecting gluten and spoiled food. We measured the social impact of the hGLUTEN tool using two Likert scale surveys with two groups: professionals (engineers/chefs) and end-users. These data have been assessed in...

Cite
Moreno A, Sanz G, Garcia-Zapirain B. hGLUTEN Tool: Measuring Its Social Impact Indicators. Int J Environ Res Public Health. 2021;18(23)doi: 10.3390/ijerph182312722.
Moreno, A., Sanz, G., & Garcia-Zapirain, B. (2021). hGLUTEN Tool: Measuring Its Social Impact Indicators. International journal of environmental research and public health, 18(23), . https://doi.org/10.3390/ijerph182312722
Moreno, Antonia, et al. "hGLUTEN Tool: Measuring Its Social Impact Indicators." International journal of environmental research and public health vol. 18,23 (2021). doi: https://doi.org/10.3390/ijerph182312722
Moreno A, Sanz G, Garcia-Zapirain B. hGLUTEN Tool: Measuring Its Social Impact Indicators. Int J Environ Res Public Health. 2021 Dec 02;18(23). doi: 10.3390/ijerph182312722. PMID: 34886446; PMCID: PMC8657479.
Copy Download .nbib Format: NLM
Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe.

BMC public health

Divajeva D, Marsh T, Logstrup S, Kestens M, Vemer P, Kriaucioniene V, Peresson S, O'Kelly S, Rito A, Webber L.
PMID: 24886110
BMC Public Health. 2014 May 16;14:456. doi: 10.1186/1471-2458-14-456.

BACKGROUND: The majority of chronic disease is caused by risk factors which are mostly preventable. Effective interventions to reduce these risks are known and proven to be applicable to a variety of settings. Chronic disease is generally developed long...

Cite
Divajeva D, Marsh T, Logstrup S, et al. Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe. BMC Public Health. 2014;14:456doi: 10.1186/1471-2458-14-456.
Divajeva, D., Marsh, T., Logstrup, S., Kestens, M., Vemer, P., Kriaucioniene, V., Peresson, S., O'Kelly, S., Rito, A., & Webber, L. (2014). Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe. BMC public health, 14456. https://doi.org/10.1186/1471-2458-14-456
Divajeva, Diana, et al. "Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe." BMC public health vol. 14 (2014): 456. doi: https://doi.org/10.1186/1471-2458-14-456
Divajeva D, Marsh T, Logstrup S, Kestens M, Vemer P, Kriaucioniene V, Peresson S, O'Kelly S, Rito A, Webber L. Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe. BMC Public Health. 2014 May 16;14:456. doi: 10.1186/1471-2458-14-456. PMID: 24886110; PMCID: PMC4047783.
Copy Download .nbib Format: NLM
Showing 2545 to 2548 of 2548 entries